velpatasvir
Selected indexed studies
- Velpatasvir. (, 2006) [PMID:29999897]
- Sofosbuvir/velpatasvir/voxilaprevir for hepatitis C. (Aust Prescr, 2019) [PMID:31363313]
- Safety and efficacy of sofosbuvir-velpatasvir: A meta-analysis. (Medicine (Baltimore), 2022) [PMID:36281168]
_Worker-drafted node — pending editorial review._
Connections
velpatasvir is a side effect of
Sources
- Sofosbuvir/velpatasvir for the treatment of hepatitis C in pediatric patients. (2021) pubmed
- Sofosbuvir/Velpatasvir/Voxilaprevir: A Review in Chronic Hepatitis C. (2018) pubmed
- Sofosbuvir/Velpatasvir/Voxilaprevir: A Pan-Genotypic Direct-Acting Antiviral Combination for Hepatitis C. (2018) pubmed
- Safety and efficacy of sofosbuvir-velpatasvir: A meta-analysis. (2022) pubmed
- Sofosbuvir/Velpatasvir: A Review in Chronic Hepatitis C. (2016) pubmed
- Velpatasvir. (2006) pubmed
- Sofosbuvir/velpatasvir/voxilaprevir for hepatitis C. (2019) pubmed
- Profile of sofosbuvir/velpatasvir/voxilaprevir in the treatment of hepatitis C. (2019) pubmed
- Sofosbuvir/Velpatasvir - A Promising Treatment for Chronic Hepatitis C Virus Infection. (2021) pubmed
- Sofosbuvir with velpatasvir. (2017) pubmed